<DOC>
	<DOCNO>NCT01138748</DOCNO>
	<brief_summary>Surgical resection mediastinal lymph node sample currently therapy choice early stage ( I-II ) non-small cell lung cancer ( NSCLC ) . Selected patient unwilling unable tolerate surgery refer so-called 'curative ' high dose radiotherapy . This show result long term local disease control rate high cancer specific survival . The current trial address issue progression free survival ( PFS ) patient treat radiotherapy predict multi-variate model derive composite bio-imaging biomarkers</brief_summary>
	<brief_title>Prediction Effectiveness Hypofractionated Radiation Therapy Early Stage Lung Cancer Bio-imaging Biomarkers</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Proof cT1a/b 2a/b N0M0 NSCLC Informed Consent sign Resectable tumour &gt; 18 year old men woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>inoperable early stage non-small cell lung cancer</keyword>
	<keyword>radiation therapy</keyword>
</DOC>